These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 24335848

  • 1. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
    Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, Hagen K.
    Cephalalgia; 2014 Jun; 34(7):523-32. PubMed ID: 24335848
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
    Hagen K, Brenner E, Linde M, Gravdahl GB, Tronvik EA, Engstrøm M, Sonnewald U, Helde G, Stovner LJ, Sand T.
    Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
    [Abstract] [Full Text] [Related]

  • 4. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
    Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N, DIRECT Programme Study Group.
    Lancet; 2008 Oct 18; 372(9647):1385-93. PubMed ID: 18823658
    [Abstract] [Full Text] [Related]

  • 5. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
    Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK, DIRECT Programme Study Group.
    Lancet; 2008 Oct 18; 372(9647):1394-402. PubMed ID: 18823656
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME, Dodick DW, Rapoport AM, Silberstein SD, Ma Y, Yang R, Loupe PS, Burstein R, Newman LC, Lipton RB.
    Lancet Neurol; 2015 Nov 18; 14(11):1081-90. PubMed ID: 26432182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
    Charles JA, Jotkowitz S, Byrd LH.
    Headache; 2006 Mar 18; 46(3):503-7. PubMed ID: 16618270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
    Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J.
    Acta Neurol Scand; 1984 Jan 18; 69(1):1-8. PubMed ID: 6367336
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
    Loo LS, Ailani J, Schim J, Baygani S, Hundemer HP, Port M, Krege JH.
    J Headache Pain; 2019 Jul 24; 20(1):84. PubMed ID: 31340760
    [Abstract] [Full Text] [Related]

  • 17. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial.
    Diener HC, Gendolla A, Feuersenger A, Evers S, Straube A, Schumacher H, Davidai G.
    Cephalalgia; 2009 Sep 24; 29(9):921-7. PubMed ID: 19250283
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
    Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS.
    Lancet Neurol; 2014 Sep 24; 13(9):885-92. PubMed ID: 25127173
    [Abstract] [Full Text] [Related]

  • 19. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
    Chowdhury D, Bansal L, Duggal A, Datta D, Mundra A, Krishnan A, Koul A, Gupta A.
    Cephalalgia; 2022 Apr 24; 42(4-5):396-408. PubMed ID: 34579560
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E, Putananickal N, Orsini AL, Schmidt S, Vogt DR, Cichon S, Sandor P, Fischer D.
    Trials; 2019 Jan 17; 20(1):61. PubMed ID: 30654835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.